Femasys (FEMY) Preferred Stock Liabilities (2020 - 2021)

Name: Femasys (FEMY) Preferred Stock Liabilities (2020 - 2021) | Business Quant
Creator: Business Quant

Femasys posted quarterly Preferred Stock Liabilities of $55.3 million for Q1 2021, little changed on a QoQ basis from $55.3 million in Q4 2020.

Femasys (FEMY) has 2 years of Preferred Stock Liabilities data on file, last reported at $55.3 million in Q1 2021.

For the quarter ending Q1 2021, Preferred Stock Liabilities changed N/A year-over-year to $55.3 million; the trailing twelve-month figure through Mar 2021 stood at $55.3 million (changed N/A YoY), and the FY2020 full-year result was $55.3 million, changed N/A from the prior year.
Preferred Stock Liabilities for Q1 2021 stood at $55.3 million, roughly flat from $55.3 million in the prior quarter.
Across five years, Preferred Stock Liabilities topped out at $55.3 million in Q2 2020 and bottomed at $55.3 million in Q2 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn	-
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn	-
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn	-
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn	-
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn	-
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn	-
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn	-
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn	-
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn	-
10	Femasys	22.30 Mn	16.91 Mn	-	-

Download Data 🔒